XML 55 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity Incentive Award Plan (Details) - 2010 Plan - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2017
Equity Incentive Plan    
Shares of common stock reserved for issuance   6,000,000
Shares of common stock that were available for issuance   3,046,822
Stock Options    
Number of Shares Subject to Option    
Options outstanding at the beginning of the period (in shares)   265,550
Exercised (in shares)   (190,448)
Options outstanding at the end of the period (in shares)   75,102
Weighted Average Exercise Price    
Options outstanding at the beginning of the period (in dollars per share)   $ 22.96
Exercised (in dollars per share)   24.56
Options outstanding at the end of the period (in dollars per share)   $ 19.15
Number of Shares Subject to Option    
Unvested balance at the beginning of the period (in shares)   16,323
Vested (in shares)   (16,323)
Weighted Average Fair Value at Grant    
Unvested balance at the beginning of the period (in dollars per share)   $ 9.99
Vested (in dollars per share)   $ 9.99
Restricted Awards    
Restricted Awards and PSA's    
Unvested balance at the beginning of the period (in shares)   323,641
Granted (in shares)   137,260
Forfeited (in shares)   (29,806)
Vested (in shares)   (127,517)
Unvested balance at the end of the period (in shares)   303,578
Weighted Average Fair Value at Grant    
Unvested balance at the beginning of the period (in dollars per share)   $ 53.84
Granted (in dollars per share)   86.24
Forfeited (in dollars per share)   63.84
Vested (in dollars per share)   42.69
Unvested balance at the end of the period (in dollars per share)   $ 70.54
Compensation cost not yet recognized    
Unearned compensation   $ 18.6
Restricted Awards | Weighted Average    
Compensation cost not yet recognized    
Vesting period   2 years 8 months 12 days
PSAs    
Compensation cost not yet recognized    
Unearned compensation   $ 4.4
Assumptions used to value the stock options granted    
Expected term 2 years 9 months 29 days 2 years 9 months 22 days
Expected volatility (as a percent) 25.29% 23.33%
Risk-free rate (as a percent) 0.97% 1.60%
PSAs | Weighted Average    
Weighted Average Fair Value at Grant    
Unvested balance at the beginning of the period (in dollars per share)   $ 54.24
Granted (in dollars per share)   105.50
Forfeited (in dollars per share)   79.09
Vested (in dollars per share)   25.89
Unvested balance at the end of the period (in dollars per share)   $ 84.63
Compensation cost not yet recognized    
Vesting period   2 years 3 months 18 days
PSAs | Minimum    
Restricted Awards and PSA's    
Unvested balance at the beginning of the period (in shares)   44,835
Granted (in shares)   7,210
Performance adjustment   62,841
Forfeited (in shares)   (5,674)
Vested (in shares)   (70,518)
Unvested balance at the end of the period (in shares)   38,694
Compensation cost not yet recognized    
Percentage of target number of shares for PSAs granted in 2014   0.00%
Percentage of target number of shares for PSAs granted in years 2015, 2016 and 2017   25.00%
Assumptions used to value the stock options granted    
Performance period   1 year
PSAs | Maximum    
Restricted Awards and PSA's    
Unvested balance at the beginning of the period (in shares)   167,725
Granted (in shares)   50,472
Forfeited (in shares)   (16,836)
Vested (in shares)   (70,518)
Unvested balance at the end of the period (in shares)   130,843
Compensation cost not yet recognized    
Percentage of target number of shares for PSAs granted in 2014   150.00%
Percentage of target number of shares for PSAs granted in years 2015, 2016 and 2017   175.00%
Assumptions used to value the stock options granted    
Performance period   3 years
PSAs | Target    
Restricted Awards and PSA's    
Unvested balance at the beginning of the period (in shares)   113,976
Granted (in shares)   28,841
Performance adjustment   23,725
Forfeited (in shares)   (11,255)
Vested (in shares)   (70,518)
Unvested balance at the end of the period (in shares)   84,769